Antoine De Pauw
Biographic Data
| ID | 7902595 |
|---|---|
| NAME | Antoine De Pauw |
| GIVEN NAMES | Antoine |
| FAMILY NAME | De Pauw |
| SIGNATURE | DE PAUW A |
| AFFILIATIONS | Institut Curie |
| ORCID | 0000-0003-3898-073X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Familial disclosure by genetic healthcare professionals: A useful but sparingly used legal provision in France
Familial disclosure of genetic information is an important, long-standing ethical issue that still gives rise to much debate. In France, recent legislation has created an innovative and unprecedented procedure that allows healthcare professionals (HCPs), under certain conditions, to disclose relevant information to relatives of a person carrying a deleterious genetic mutation. This article will analyse how HCPs in two medical genetics clinics hav…
Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: An international survey
The BOADICEA breast cancer (BC) risk assessment model and its associated Web Application v3 (BWA) tool are being extended to incorporate additional genetic and non-genetic BC risk factors. From an online survey through the BOADICEA website and UK, Dutch, French and Swedish national genetic societies, we explored the relationships between the usage frequencies of the BWA and six other common BC risk assessment tools and respondents' perceived impo…
Patient-Centered Care in Breast Cancer Genetic Clinics
With advances in breast cancer (BC) gene panel testing, risk counseling has become increasingly complex, potentially leading to unmet psychosocial needs. We assessed psychosocial needs and correlates in women initiating testing for high genetic BC risk in clinics in France and Germany, and compared these results with data from a literature review. Among the 442 counselees consecutively approached, 212 (83%) in France and 180 (97%) in Germany, mos…
No prominent works on this page.
Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: An international survey
The BOADICEA breast cancer (BC) risk assessment model and its associated Web Application v3 (BWA) tool are being extended to incorporate additional genetic and non-genetic BC risk factors. From an online survey through the BOADICEA website and UK, Dutch, French and Swedish national genetic societies, we explored the relationships between the usage frequencies of the BWA and six other common BC risk assessment tools and respondents' perceived impo…
Patient-Centered Care in Breast Cancer Genetic Clinics
With advances in breast cancer (BC) gene panel testing, risk counseling has become increasingly complex, potentially leading to unmet psychosocial needs. We assessed psychosocial needs and correlates in women initiating testing for high genetic BC risk in clinics in France and Germany, and compared these results with data from a literature review. Among the 442 counselees consecutively approached, 212 (83%) in France and 180 (97%) in Germany, mos…
Familial disclosure by genetic healthcare professionals: A useful but sparingly used legal provision in France
Familial disclosure of genetic information is an important, long-standing ethical issue that still gives rise to much debate. In France, recent legislation has created an innovative and unprecedented procedure that allows healthcare professionals (HCPs), under certain conditions, to disclose relevant information to relatives of a person carrying a deleterious genetic mutation. This article will analyse how HCPs in two medical genetics clinics hav…
BRCA gene mutations in cancer (3 works) · Medicine (3 works) · Breast cancer (2 works) · Cancer (2 works) · Demography (2 works) · Demography (2 works) · Family medicine (2 works) · Gerontology (2 works) · Internal Medicine (2 works) · Anxiety (1 works)